Biomarker Research

Article	Citations
The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma	149
Skin-permeable gold nanoparticles with modifications azelamide monoethanolamine ameliorate inflammatory skin diseases	144
The spatial impact of a Western diet in enriching Galectin-1-regulated Rho, ECM, and SASP signaling in a novel MASH-HCC mouse model	124
CardioAtlas: deciphering the single-cell transcriptome landscape in cardiovascular tissues and diseases	121
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors	115
Exosomal PSM-E inhibits macrophage M2 polarization to suppress prostate cancer metastasis through the RACK1 signaling axis	106
Identification of GRIN2D as a novel therapeutic target in pancreatic ductal adenocarcinoma	99
Mitochondrial transfer in hematological malignancies	97
Advances in the DNA methylation hydroxylase TET1	96
Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients	96
Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer	90
Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology	87
Extracellular vesicles-derived miR-21 as a biomarker for early diagnosis and tumor activity in breast cancer subtypes	85
A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma	79
Dynamic changes of bone microarchitecture and volumetric mineral density assessed by HR-pQCT in patients with cervical cancer after concurrent chemoradiotherapy: a prospective study	76
mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends	71
p53 biology and reactivation for improved therapy in MDS and AML	67
Copper homeostasis and copper-induced cell death in tumor immunity: implications for therapeutic strategies in cancer immunotherapy	61
Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions	59
Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC	58
Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells	57
Monocyte-macrophages modulate intestinal homeostasis in inflammatory bowel disease	54
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy	54
Donor T cells for CAR T cell therapy	53
Unveiling the potential of CLL-1: a promising target for AML therapy	52

The overlooked trio: sleep duration, sampling time and physical exercise alter levels of olink-assessed blood biomarkers of cardiovascular risk	50
Targeting interleukin-1β and inflammation in lung cancer	47
Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients	47
Integrated analysis of spatial transcriptomics and CT phenotypes for unveiling the novel molecular characteristics of recurrent and non-recurrent high-grade serous ovarian cancer	47
STAT3–mediated up-regulation of DAB2 via SRC-YAP1 signaling axis promotes Helicobacter pylori-driven gastric tumorigenesis	46
The role and metabolic adaptations of neutrophils in premetastatic niches	45
Correction: Manipulation of cancer cell pyroptosis for therapeutic approaches: challenges and opportunities	45
Dysregulation of plasma circulating microRNAs in all-cause and cause-specific cancers: the Rotterdam Study	45
RUNX1 promotes angiogenesis in colorectal cancer by regulating the crosstalk between tumor cells and tumor associated macrophages	43
Multiple regulatory events contribute to a widespread circular RNA downregulation in precancer and early stage of colorectal cancer development	42
Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnostics	42
The role of BATF in immune cell differentiation and autoimmune diseases	42
Correction: Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation	41
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy	41
Oncogenic ACSM6 impairs CD8+ T cell-based immune response in bladder cancer	40
The involvement of krüppel-like transcription factor 2 in megakaryocytic differentiation induction by phorbol 12-myrestrat 13-acetate	40
Immunophenotypic analysis on circulating T cells for early diagnosis of lung cancer	40
Long-term kinetics of proviral load in HTLV-1 carriers: defining risk for the development of adult T-cell leukemia/lymphoma	39
Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions	39
BRD4: an effective target for organ fibrosis	39
Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas	38
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy	38
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis	37
Temporal trend of gastric cancer burden along with its risk factors in China from 1990 to 2019, and projections until 2030: comparison with Japan, South Korea, and Mongolia	37
Correction: Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential	36
Current advances and future perspectives on the functional roles and clinical implications of circular RNAs in esophageal squamous cell carcinoma: more influential than expected	36
Comparison of proton therapy and photon therapy for early-stage non-small cell lung cancer: a meta-analysis	35
Nucleases as molecular targets for cancer diagnosis	35
Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential	33
Updates on CAR T cell therapy in multiple myeloma	33
Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications	32
Correction: Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation	32
The lncRNA TEX41 is upregulated in pediatric B-Cells Acute Lymphoblastic Leukemia and it is necessary for leukemic cell growth	32
Next frontier in tumor immunotherapy: macrophage-mediated immune evasion	31
Intratumor microbiome in cancer progression: current developments, challenges and future trends	31
The essential roles of FXR in diet and age influenced metabolic changes and liver disease development: a multi-omics study	31
Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis	31
Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors	30
Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance	30
Fatty acid metabolism shapes immune responses in chronic lymphocytic leukemia	30
MORF4L2 induces immunosuppressive microenvironment and immunotherapy resistance through GRHL2/MORF4L2/H4K12Ac/CSF1 axis in triple-negative breast cancer	29
Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients	28
The importance of critically short telomere in myelodysplastic syndrome	28
Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer	28
Combined TP53 status in tumor-free resection margins and circulating microRNA profiling predicts the risk of locoregional recurrence in head and neck cancer	28
Analyzing PKC Gamma (+ 19,506 A/G) polymorphism as a promising genetic marker for HCV-induced hepatocellular carcinoma	27
Soluble PD-L1 as a novel biomarker predicts poor outcomes and disease progression in de novo myelodysplastic syndromes	27
Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer	27
Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives	27
Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers	26

Single-cell RNA sequencing identifies a subtype of FN1 + tumor-associated macrophages associated with glioma recurrence and as a biomarker for immunotherapy	25
Structures and biological functions of zinc finger proteins and their roles in hepatocellular carcinoma	25
Targeting cGAS-STING pathway for reprogramming tumor-associated macrophages to enhance anti-tumor immunotherapy	25
Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samples	24
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma	24
FGL1 and FGL2: emerging regulators of liver health and disease	24
NLRP4 unlocks an NK/macrophages-centered ecosystem to suppress non-small cell lung cancer	24
Targeting CD47/SIRPα as a therapeutic strategy, where we are and where we are headed	24
Tobacco smoking associates with NF1 mutations exacerbating survival outcomes in gliomas	24
Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives	24
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives	23
New cell sources for CAR-based immunotherapy	23
Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma	23
Targeted protein degradation in hematologic malignancies: clinical progression towards novel therapeutics	23
Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives	23
Challenges and advances for huntingtin detection in cerebrospinal fluid: in support of relative quantification	22
Nanobody-enhanced chimeric antigen receptor T-cell therapy: overcoming barriers in solid tumors with VHH and VNAR-based constructs	22
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool	22
Association between circulating ECM-associated molecules and cardiovascular outcomes in hemodialysis patients: a multicenter prospective cohort study	21
METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer	21
E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors	21
EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway	20
Targeting NOX2 and glycolytic metabolism as a therapeutic strategy in acute myeloid leukaemia	20
Association of CAR-T approval on outcomes in patients with diffuse large B-cell lymphoma at the population level in the United States	20
Application of double-negative T cells in haematological malignancies: recent progress and future directions	20
SRTdb: an omnibus for human tissue and cancer-specific RNA transcripts	19
Human induced-T-to-natural killer cells have potent anti-tumour activities	19
Single-cell multi-omics analysis identifies SPP1+ macrophages as key drivers of ferroptosis-mediated fibrosis in ligamentum flavum hypertrophy	19
Correction: CRISPR/Cas-based CAR-T cells: production and application	19
MiRNAs as potential therapeutic targets and biomarkers for non-traumatic intracerebral hemorrhage	19
The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases	18
The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer	18
Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies	18
Targeting TIGIT for cancer immunotherapy: recent advances and future directions	18
The significant others of aurora kinase a in cancer: combination is the key	17
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression	17
Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cell lung cancer	17
A germline FLT3 variant in aplastic anemia	17
Long noncoding RNA LIPH-4 promotes esophageal squamous cell carcinoma progression by regulating the miR-216b/IGF2BP2 axis	17
PTK2 is a potential biomarker and therapeutic target for EGFR- or TLRs-induced lung cancer progression via the regulation of the cross-talk between EGFR- and TLRs-mediated signals	16
Toll-like receptor 3: a double-edged sword	16
Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response	16
Cervical cancer heterogeneity: a constant battle against viruses and drugs	16
The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer	16
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted	16
PCSK9 in T-cell function and the immune response	16
Ribosome profiling: a powerful tool in oncological research	16
High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma	16
The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications	16
Oncogenic alterations in advanced NSCLC: a molecular super-highway	16
Blood and urine biomarkers of disease progression in IgA nephropathy	15
The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets	15
The detection, biological function, and liquid biopsy application of extracellular vesicle-associated DNA	15
Noninvasive biomarkers implicated in urea and TCA cycles for metabolic liver disease	15
Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects	15
Correction: LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/ miR-324-3p-SIRT5 axis in lung adenocarcinoma	15
MACC1 revisited – an in-depth review of a master of metastasis	15
LncRNA AC006064.4–201 serves as a novel molecular marker in alleviating cartilage senescence and protecting against osteoarthritis by destabilizing CDKN1B mRNA via interacting with PTBP1	15
The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies	14
Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression	14
HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma	14
The role of pyroptosis in modulating the tumor immune microenvironment	14
Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer	14
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients	13
TRPM channels in human cancers: regulatory mechanism and therapeutic prospects	13
Tumor microenvironment and immunotherapy for triple-negative breast cancer	13
Vitamin D activates FBP1 to block the Warburg effect and modulate blast metabolism in acute myeloid leukemia	13
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia	13
Correction: Deciphering LAG-3: unveiling molecular mechanisms and clinical advancements	13
Circulating long non-coding RNAs detection after heart transplantation and its accuracy in the diagnosis of acute cardiac rejection	13
Comprehensive plasma metabolomics profiling develops diagnostic biomarkers of obstructive hypertrophic cardiomyopathy	13
Exploring non-invasive precision treatment in non-small cell lung cancer patients through deep learning radiomics across imaging features and molecular phenotypes	13
Review immune response of targeting CD39 in cancer	13
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation	13
Phenomic landscape and pharmacogenomic implications for HLA region in a Taiwan Han Chinese population	13
Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy	13
Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling	13
Revolutionizing oncology: the role of Artificial Intelligence (AI) as an antibody design, and optimization tools	13
Sintilimab for the treatment of non-small cell lung cancer	12
Roles of posttranslational modifications in lipid metabolism and cancer progression	12

Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia	12
Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer	12
Minimal residual disease in multiple myeloma: current status	12
Gene therapy for polygenic or complex diseases	12
Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies	12
Correction: Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer	12
CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond	12
Global, regional, and national burden of heart failure and its underlying causes, 1990–2021: results from the global burden of disease study 2021	12
CRISPR/Cas-based CAR-T cells: production and application	12
Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers	11
Detection of circulating tumor cells: opportunities and challenges	11
Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia	11
Imaging biomarkers for evaluating tumor response: RECIST and beyond	11
The role of platelets in cancer: from their influence on tumor progression to their potential use in liquid biopsy	11
Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation	11
Biological roles of RNA m5C modification and its implications in Cancer immunotherapy	11
Correction: Vitamin D activates FBP1 to block the Warburg effect and modulate blast metabolism in acute myeloid leukemia	11
Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression	10
A functional role of Ephrin type-B receptor 6 (EPHB6) in T-cell acute lymphoblastic leukemia	10
Global surveillance of circulating microRNA for diagnostic and prognostic assessment of acute myocardial infarction based on the plasma small RNA sequencing	10
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study	10
LRG1, a novel serum biomarker for iMCD disease activity	10
DeepMPTB: a vaginal microbiome-based deep neural network as artificial intelligence strategy for efficient preterm birth prediction	10
Integrative multi-omics analysis depicts the methylome and hydroxymethylome in recurrent bladder cancers and identifies biomarkers for predicting PD-L1 expression	10
Biomarkers as targets for CAR-T/NK cell therapy in AML	10
Correction: A novel 3-miRNA network regulates tumour progression in oral squamous cell carcinoma	10
Serum metabolite signatures of cardiac function and morphology in individuals from a population-based cohort	10
Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the Global Burden of Disease Study 2021	9
Folate receptor 1 is a stemness trait-associated diagnostic and prognostic marker for hepatocellular carcinoma	9
Heat shock proteins (HSPs) in non-alcoholic fatty liver disease (NAFLD): from molecular mechanisms to therapeutic avenues	9
Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma	9
Circulating MicroRNAs predict glycemic improvement and response to a behavioral intervention	9
The telomere complex and the origin of the cancer stem cell	9
Untargeted lipidomics reveals racial differences in lipid species among women	9
SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma	9
Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS study	9
The war between the immune system and the tumor - using immune biomarkers as tracers	9
Functions of RNA N6-methyladenosine modification in acute myeloid leukemia	9
Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model	9
The role of biomarkers in personalized immunotherapy	8
Current challenges and best practices for cell-free long RNA biomarker discovery	8
Emerging treatment modalities for systemic therapy in hepatocellular carcinoma	8
Characterization of T-Cell receptor repertoire in immunoglobulin a nephropathy	8
Repressing HIF-1α-induced HDAC9 contributes to the synergistic effect of venetoclax and MENIN inhibitor in KMT2Ar AML	8
Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis	8
Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective	8
Single cell spatial profiling of FFPE splenic tissue from a humanized mouse model of HIV infection	8
KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma	8
The application of Aptamer in biomarker discovery	8
Integrating artificial intelligence in drug discovery and early drug development: a transformative approach	8
Advances of cancer-associated fibroblasts in liver cancer	8
Advancement in Multi-omics approaches for Uterine Sarcoma	8
Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications	8
Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma	8
Targeting myeloid cells for hematological malignancies: the present and future	7
Bioinformatics tools and data resources for assay development of fluid protein biomarkers	7
Microfluidic biosensors for biomarker detection in body fluids: a key approach for early cancer diagnosis	7
Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases	7
Epidemiological trends of women’s cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study	7
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma	7
The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy	7
The landscape overview of CD47-based immunotherapy for hematological malignancies	7
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair	7
A comprehensive comparison between camelid nanobodies and single chain variable fragments	7
Advances in technology and applications of nanoimmunotherapy for cancer	7
The Musashi RNA-binding proteins in female cancers: insights on molecular mechanisms and therapeutic relevance	7
The landscape of bispecific T cell engager in cancer treatment	7
AXL in myeloid malignancies – an elusive target?	7
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives	6
Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells	6
Lectins as potential tools for cancer biomarker discovery from extracellular vesicles	6
Novel insights into the role of immunomodulatory extracellular vesicles in the pathogenesis of liver fibrosis	6
The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy	6
Insights into genetic aberrations and signalling pathway interactions in chronic lymphocytic leukemia: from pathogenesis to treatment strategies	6
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies	6
Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia	6
X-chromosome-linked miR-542-5p as a key regulator of sex disparity in rats with adjuvant-induced arthritis by promoting Th17 differentiation	6
singleCellBase: a high-quality manually curated database of cell markers for single cell annotation across multiple species	6
METTL1 promotes neuroblastoma development through m7G tRNA modification and selective oncogenic gene translation	6
MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures	6
Dysregulation of transposable elements and PIWI-interacting RNAs in myelodysplastic neoplasms	6
Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era	6
The Wnt/β-catenin signalling pathway in Haematological Neoplasms	5
The solute carrier transporters (SLCs) family in nutrient metabolism and ferroptosis	5
METTL protein family: focusing on the occurrence, progression and treatment of cancer	5
Circulating extracellular vesicles during pregnancy in women with type 1 diabetes: a secondary analysis of the CONCEPTT trial	5
Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment	5
MicroRNAs predict early complications of autologous hematopoietic stem cell transplantation	5
Tumor reversion: a dream or a reality	5
Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B	5
Radiogenomic association of deep MR imaging features with genomic profiles and clinical characteristics in breast cancer	5
Decoding burn trauma: biomarkers for early diagnosis of burn-induced pathologies	5
Single-cell, single-nucleus and xenium-based spatial transcriptomics analyses reveal inflammatory activation and altered cell interactions in the hippocampus in mice with temporal lobe epilepsy	5
Extrachromosomal circular DNA (eccDNA): an emerging star in cancer	5
A metabolite-based liquid biopsy for detection of ovarian cancer	5